Cholera Vaccine (Oral Route) Market, Global Outlook and Forecast 2022-2028

February 2022 | 75 pages | ID: C7BC3E96978FEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Cholera Vaccine (Oral Route) in global, including the following market information:

Global Cholera Vaccine (Oral Route) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Cholera Vaccine (Oral Route) Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Cholera Vaccine (Oral Route) companies in 2021 (%)

The global Cholera Vaccine (Oral Route) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Shanchol Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cholera Vaccine (Oral Route) include PaxVax, Sanofi, Valneva and EuBiologics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cholera Vaccine (Oral Route) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cholera Vaccine (Oral Route) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cholera Vaccine (Oral Route) Market Segment Percentages, by Type, 2021 (%)
  • Shanchol
  • Dukoral
  • Vaxchora
  • Others
Global Cholera Vaccine (Oral Route) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cholera Vaccine (Oral Route) Market Segment Percentages, by Application, 2021 (%)
  • Hospital
  • Research & Academic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Others
Global Cholera Vaccine (Oral Route) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cholera Vaccine (Oral Route) Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cholera Vaccine (Oral Route) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Cholera Vaccine (Oral Route) revenues share in global market, 2021 (%)

Key companies Cholera Vaccine (Oral Route) sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Cholera Vaccine (Oral Route) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • PaxVax
  • Sanofi
  • Valneva
  • EuBiologics
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cholera Vaccine (Oral Route) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cholera Vaccine (Oral Route) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CHOLERA VACCINE (ORAL ROUTE) OVERALL MARKET SIZE

2.1 Global Cholera Vaccine (Oral Route) Market Size: 2021 VS 2028
2.2 Global Cholera Vaccine (Oral Route) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Cholera Vaccine (Oral Route) Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Cholera Vaccine (Oral Route) Players in Global Market
3.2 Top Global Cholera Vaccine (Oral Route) Companies Ranked by Revenue
3.3 Global Cholera Vaccine (Oral Route) Revenue by Companies
3.4 Global Cholera Vaccine (Oral Route) Sales by Companies
3.5 Global Cholera Vaccine (Oral Route) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Cholera Vaccine (Oral Route) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Cholera Vaccine (Oral Route) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cholera Vaccine (Oral Route) Players in Global Market
  3.8.1 List of Global Tier 1 Cholera Vaccine (Oral Route) Companies
  3.8.2 List of Global Tier 2 and Tier 3 Cholera Vaccine (Oral Route) Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Cholera Vaccine (Oral Route) Market Size Markets, 2021 & 2028
  4.1.2 Shanchol
  4.1.3 Dukoral
  4.1.4 Vaxchora
  4.1.5 Others
4.2 By Type - Global Cholera Vaccine (Oral Route) Revenue & Forecasts
  4.2.1 By Type - Global Cholera Vaccine (Oral Route) Revenue, 2017-2022
  4.2.2 By Type - Global Cholera Vaccine (Oral Route) Revenue, 2023-2028
  4.2.3 By Type - Global Cholera Vaccine (Oral Route) Revenue Market Share, 2017-2028
4.3 By Type - Global Cholera Vaccine (Oral Route) Sales & Forecasts
  4.3.1 By Type - Global Cholera Vaccine (Oral Route) Sales, 2017-2022
  4.3.2 By Type - Global Cholera Vaccine (Oral Route) Sales, 2023-2028
  4.3.3 By Type - Global Cholera Vaccine (Oral Route) Sales Market Share, 2017-2028
4.4 By Type - Global Cholera Vaccine (Oral Route) Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cholera Vaccine (Oral Route) Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Research & Academic Laboratories
  5.1.4 Pharmaceutical & Biotechnology Companies
  5.1.5 Others
5.2 By Application - Global Cholera Vaccine (Oral Route) Revenue & Forecasts
  5.2.1 By Application - Global Cholera Vaccine (Oral Route) Revenue, 2017-2022
  5.2.2 By Application - Global Cholera Vaccine (Oral Route) Revenue, 2023-2028
  5.2.3 By Application - Global Cholera Vaccine (Oral Route) Revenue Market Share, 2017-2028
5.3 By Application - Global Cholera Vaccine (Oral Route) Sales & Forecasts
  5.3.1 By Application - Global Cholera Vaccine (Oral Route) Sales, 2017-2022
  5.3.2 By Application - Global Cholera Vaccine (Oral Route) Sales, 2023-2028
  5.3.3 By Application - Global Cholera Vaccine (Oral Route) Sales Market Share, 2017-2028
5.4 By Application - Global Cholera Vaccine (Oral Route) Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cholera Vaccine (Oral Route) Market Size, 2021 & 2028
6.2 By Region - Global Cholera Vaccine (Oral Route) Revenue & Forecasts
  6.2.1 By Region - Global Cholera Vaccine (Oral Route) Revenue, 2017-2022
  6.2.2 By Region - Global Cholera Vaccine (Oral Route) Revenue, 2023-2028
  6.2.3 By Region - Global Cholera Vaccine (Oral Route) Revenue Market Share, 2017-2028
6.3 By Region - Global Cholera Vaccine (Oral Route) Sales & Forecasts
  6.3.1 By Region - Global Cholera Vaccine (Oral Route) Sales, 2017-2022
  6.3.2 By Region - Global Cholera Vaccine (Oral Route) Sales, 2023-2028
  6.3.3 By Region - Global Cholera Vaccine (Oral Route) Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Cholera Vaccine (Oral Route) Revenue, 2017-2028
  6.4.2 By Country - North America Cholera Vaccine (Oral Route) Sales, 2017-2028
  6.4.3 US Cholera Vaccine (Oral Route) Market Size, 2017-2028
  6.4.4 Canada Cholera Vaccine (Oral Route) Market Size, 2017-2028
  6.4.5 Mexico Cholera Vaccine (Oral Route) Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Cholera Vaccine (Oral Route) Revenue, 2017-2028
  6.5.2 By Country - Europe Cholera Vaccine (Oral Route) Sales, 2017-2028
  6.5.3 Germany Cholera Vaccine (Oral Route) Market Size, 2017-2028
  6.5.4 France Cholera Vaccine (Oral Route) Market Size, 2017-2028
  6.5.5 U.K. Cholera Vaccine (Oral Route) Market Size, 2017-2028
  6.5.6 Italy Cholera Vaccine (Oral Route) Market Size, 2017-2028
  6.5.7 Russia Cholera Vaccine (Oral Route) Market Size, 2017-2028
  6.5.8 Nordic Countries Cholera Vaccine (Oral Route) Market Size, 2017-2028
  6.5.9 Benelux Cholera Vaccine (Oral Route) Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Cholera Vaccine (Oral Route) Revenue, 2017-2028
  6.6.2 By Region - Asia Cholera Vaccine (Oral Route) Sales, 2017-2028
  6.6.3 China Cholera Vaccine (Oral Route) Market Size, 2017-2028
  6.6.4 Japan Cholera Vaccine (Oral Route) Market Size, 2017-2028
  6.6.5 South Korea Cholera Vaccine (Oral Route) Market Size, 2017-2028
  6.6.6 Southeast Asia Cholera Vaccine (Oral Route) Market Size, 2017-2028
  6.6.7 India Cholera Vaccine (Oral Route) Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Cholera Vaccine (Oral Route) Revenue, 2017-2028
  6.7.2 By Country - South America Cholera Vaccine (Oral Route) Sales, 2017-2028
  6.7.3 Brazil Cholera Vaccine (Oral Route) Market Size, 2017-2028
  6.7.4 Argentina Cholera Vaccine (Oral Route) Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Cholera Vaccine (Oral Route) Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Cholera Vaccine (Oral Route) Sales, 2017-2028
  6.8.3 Turkey Cholera Vaccine (Oral Route) Market Size, 2017-2028
  6.8.4 Israel Cholera Vaccine (Oral Route) Market Size, 2017-2028
  6.8.5 Saudi Arabia Cholera Vaccine (Oral Route) Market Size, 2017-2028
  6.8.6 UAE Cholera Vaccine (Oral Route) Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 PaxVax
  7.1.1 PaxVax Corporate Summary
  7.1.2 PaxVax Business Overview
  7.1.3 PaxVax Cholera Vaccine (Oral Route) Major Product Offerings
  7.1.4 PaxVax Cholera Vaccine (Oral Route) Sales and Revenue in Global (2017-2022)
  7.1.5 PaxVax Key News
7.2 Sanofi
  7.2.1 Sanofi Corporate Summary
  7.2.2 Sanofi Business Overview
  7.2.3 Sanofi Cholera Vaccine (Oral Route) Major Product Offerings
  7.2.4 Sanofi Cholera Vaccine (Oral Route) Sales and Revenue in Global (2017-2022)
  7.2.5 Sanofi Key News
7.3 Valneva
  7.3.1 Valneva Corporate Summary
  7.3.2 Valneva Business Overview
  7.3.3 Valneva Cholera Vaccine (Oral Route) Major Product Offerings
  7.3.4 Valneva Cholera Vaccine (Oral Route) Sales and Revenue in Global (2017-2022)
  7.3.5 Valneva Key News
7.4 EuBiologics
  7.4.1 EuBiologics Corporate Summary
  7.4.2 EuBiologics Business Overview
  7.4.3 EuBiologics Cholera Vaccine (Oral Route) Major Product Offerings
  7.4.4 EuBiologics Cholera Vaccine (Oral Route) Sales and Revenue in Global (2017-2022)
  7.4.5 EuBiologics Key News

8 GLOBAL CHOLERA VACCINE (ORAL ROUTE) PRODUCTION CAPACITY, ANALYSIS

8.1 Global Cholera Vaccine (Oral Route) Production Capacity, 2017-2028
8.2 Cholera Vaccine (Oral Route) Production Capacity of Key Manufacturers in Global Market
8.3 Global Cholera Vaccine (Oral Route) Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 CHOLERA VACCINE (ORAL ROUTE) SUPPLY CHAIN ANALYSIS

10.1 Cholera Vaccine (Oral Route) Industry Value Chain
10.2 Cholera Vaccine (Oral Route) Upstream Market
10.3 Cholera Vaccine (Oral Route) Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Cholera Vaccine (Oral Route) Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Cholera Vaccine (Oral Route) in Global Market
Table 2. Top Cholera Vaccine (Oral Route) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Cholera Vaccine (Oral Route) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Cholera Vaccine (Oral Route) Revenue Share by Companies, 2017-2022
Table 5. Global Cholera Vaccine (Oral Route) Sales by Companies, (K Units), 2017-2022
Table 6. Global Cholera Vaccine (Oral Route) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Cholera Vaccine (Oral Route) Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Cholera Vaccine (Oral Route) Product Type
Table 9. List of Global Tier 1 Cholera Vaccine (Oral Route) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cholera Vaccine (Oral Route) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Cholera Vaccine (Oral Route) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Cholera Vaccine (Oral Route) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Cholera Vaccine (Oral Route) Sales (K Units), 2017-2022
Table 15. By Type - Global Cholera Vaccine (Oral Route) Sales (K Units), 2023-2028
Table 16. By Application – Global Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Cholera Vaccine (Oral Route) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Cholera Vaccine (Oral Route) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Cholera Vaccine (Oral Route) Sales (K Units), 2017-2022
Table 20. By Application - Global Cholera Vaccine (Oral Route) Sales (K Units), 2023-2028
Table 21. By Region – Global Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Cholera Vaccine (Oral Route) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Cholera Vaccine (Oral Route) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Cholera Vaccine (Oral Route) Sales (K Units), 2017-2022
Table 25. By Region - Global Cholera Vaccine (Oral Route) Sales (K Units), 2023-2028
Table 26. By Country - North America Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Cholera Vaccine (Oral Route) Sales, (K Units), 2017-2022
Table 29. By Country - North America Cholera Vaccine (Oral Route) Sales, (K Units), 2023-2028
Table 30. By Country - Europe Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Cholera Vaccine (Oral Route) Sales, (K Units), 2017-2022
Table 33. By Country - Europe Cholera Vaccine (Oral Route) Sales, (K Units), 2023-2028
Table 34. By Region - Asia Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Cholera Vaccine (Oral Route) Sales, (K Units), 2017-2022
Table 37. By Region - Asia Cholera Vaccine (Oral Route) Sales, (K Units), 2023-2028
Table 38. By Country - South America Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Cholera Vaccine (Oral Route) Sales, (K Units), 2017-2022
Table 41. By Country - South America Cholera Vaccine (Oral Route) Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Cholera Vaccine (Oral Route) Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Cholera Vaccine (Oral Route) Sales, (K Units), 2023-2028
Table 46. PaxVax Corporate Summary
Table 47. PaxVax Cholera Vaccine (Oral Route) Product Offerings
Table 48. PaxVax Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Sanofi Corporate Summary
Table 50. Sanofi Cholera Vaccine (Oral Route) Product Offerings
Table 51. Sanofi Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Valneva Corporate Summary
Table 53. Valneva Cholera Vaccine (Oral Route) Product Offerings
Table 54. Valneva Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. EuBiologics Corporate Summary
Table 56. EuBiologics Cholera Vaccine (Oral Route) Product Offerings
Table 57. EuBiologics Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Cholera Vaccine (Oral Route) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 59. Global Cholera Vaccine (Oral Route) Capacity Market Share of Key Manufacturers, 2020-2022
Table 60. Global Cholera Vaccine (Oral Route) Production by Region, 2017-2022 (K Units)
Table 61. Global Cholera Vaccine (Oral Route) Production by Region, 2023-2028 (K Units)
Table 62. Cholera Vaccine (Oral Route) Market Opportunities & Trends in Global Market
Table 63. Cholera Vaccine (Oral Route) Market Drivers in Global Market
Table 64. Cholera Vaccine (Oral Route) Market Restraints in Global Market
Table 65. Cholera Vaccine (Oral Route) Raw Materials
Table 66. Cholera Vaccine (Oral Route) Raw Materials Suppliers in Global Market
Table 67. Typical Cholera Vaccine (Oral Route) Downstream
Table 68. Cholera Vaccine (Oral Route) Downstream Clients in Global Market
Table 69. Cholera Vaccine (Oral Route) Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Cholera Vaccine (Oral Route) Segment by Type
Figure 2. Cholera Vaccine (Oral Route) Segment by Application
Figure 3. Global Cholera Vaccine (Oral Route) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cholera Vaccine (Oral Route) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cholera Vaccine (Oral Route) Revenue, 2017-2028 (US$, Mn)
Figure 7. Cholera Vaccine (Oral Route) Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Cholera Vaccine (Oral Route) Revenue in 2021
Figure 9. By Type - Global Cholera Vaccine (Oral Route) Sales Market Share, 2017-2028
Figure 10. By Type - Global Cholera Vaccine (Oral Route) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Cholera Vaccine (Oral Route) Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Cholera Vaccine (Oral Route) Sales Market Share, 2017-2028
Figure 13. By Application - Global Cholera Vaccine (Oral Route) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Cholera Vaccine (Oral Route) Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Cholera Vaccine (Oral Route) Sales Market Share, 2017-2028
Figure 16. By Region - Global Cholera Vaccine (Oral Route) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Cholera Vaccine (Oral Route) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Cholera Vaccine (Oral Route) Sales Market Share, 2017-2028
Figure 19. US Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Cholera Vaccine (Oral Route) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Cholera Vaccine (Oral Route) Sales Market Share, 2017-2028
Figure 24. Germany Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 25. France Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Cholera Vaccine (Oral Route) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Cholera Vaccine (Oral Route) Sales Market Share, 2017-2028
Figure 33. China Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 37. India Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Cholera Vaccine (Oral Route) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Cholera Vaccine (Oral Route) Sales Market Share, 2017-2028
Figure 40. Brazil Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Cholera Vaccine (Oral Route) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Cholera Vaccine (Oral Route) Sales Market Share, 2017-2028
Figure 44. Turkey Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Cholera Vaccine (Oral Route) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Cholera Vaccine (Oral Route) Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Cholera Vaccine (Oral Route) by Region, 2021 VS 2028
Figure 50. Cholera Vaccine (Oral Route) Industry Value Chain
Figure 51. Marketing Channels


More Publications